APOE and Alzheimer disease: Compared with the standard of an AD GRS(based on variants associated with clinically diagnosed AD dementia), thenon-APOE amyloid GRS explained a larger percentage ofthe phenotypic variance in both the MCSA (6.0% vs 1.0%) and ADNI (5.8% vs0%) cohorts.